Cytek Biosciences, Inc. (CTKB) Q4 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Thank you for standing by. My name is Tina and I will be your conference operator today. At this time, I would like to welcome everyone to the SciTech Science's fourth quarter 2025 earnings call. All lines have been placed on mute to prevent any background noise. After the speaker's remarks, there will be a question and answer session. To ask a question, simply press star one on your telephone keypad. To withdraw your question, press star 1 again. It is now my pleasure to turn the call over to Paul Goodson, Head of Investor Relations. You may begin. Thank you, Operator. Earlier today, SciTech Biosciences released financial results for the fourth quarter and year ended December 31st, 2025. If you haven't received this news release or you'd like to be added to the company's distribution list, please send an email to investors at scitechbio.com. A copy of the news release is also available on the investor relations section of SciTech's website at investors.scitechbio.com. Joining me today from SciTech are Wenbin Zhang, CEO, and Bill McComb, CFO. Please note that we will be referencing a slide presentation during the call today that has been posted to the investor section of our corporate website. As a reminder, on slide two, we will make statements during this call that are forward-looking statements within the meaning of the federal securities laws, including statements regarding CITAC's business plans, strategies, opportunities, and financial projections. These statements are based on the company's current expectations and inherently involve significant risks and uncertainties. that could cause actual results or events to materially differ from those anticipated in these statements. Additional information regarding these risks and uncertainties appears in our slide pr...